Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients

Clinical trial NCT03236675 · UNKNOWN

Trial details

NCT number: NCT03236675
Sponsor: Exosome Diagnostics, Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2015-03-01
Primary completion: 2022-02-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.